| Literature DB >> 10678609 |
M P Orlando1, M E Dillon, M W O'Dell.
Abstract
Subcutaneous heparin is commonly used as a prophylaxis against deep venous thrombosis in a wide variety of hospitalized patients. As with most medications, heparin has a significant side effect profile; heparin-induced hyperkalemia is an unusual but well described side effect. To increase awareness of heparin-induced hyperkalemia and of those patients at greatest risk, we present two cases of documented hyperkalemia induced by heparin and reconfirmed by drug rechallenge.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10678609 DOI: 10.1097/00002060-200001000-00019
Source DB: PubMed Journal: Am J Phys Med Rehabil ISSN: 0894-9115 Impact factor: 2.159